Primary hyperoxaluria remains undiagnosed in patients with hyperoxaluria and recurrent urolithiasis [2]

Clinical Chemistry

Volumn 53, Issue 8, 2007, Pages 1553-1555

  Van Woerden, Christiaan S ^a,c   Groothoff, Jaap W ^a   Wijburg, Frits A ^a   Waterham, Hans R ^a   Wanders, Ronald J A ^a   Janssen, Marcel J W ^b   Duran, Marinus ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VIECURI MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGXT GENE; ALLELE; DISEASE ASSOCIATION; EARLY DIAGNOSIS; GENE; GENE MUTATION; HUMAN; HYPEROXALURIA; KIDNEY CALCIFICATION; KIDNEY FAILURE; LABORATORY DIAGNOSIS; LETTER; MALABSORPTION; NEPHROLITHIASIS; OXALOSIS 1; RECURRENT DISEASE; SYMPTOMATOLOGY; UROLITHIASIS;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; HUMANS; HYPEROXALURIA; HYPEROXALURIA, PRIMARY; MIDDLE AGED; RECURRENCE; UROLITHIASIS;

EID: 34547630328     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2007.090688     Document Type: Letter

References (5)

1. Danpure CJ. Primary hyperoxaluria. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill, 2001:3323-67.
2. van Woerden CS, Groothoff JW, Wanders RJ, Davin JC, Wijburg FA. Primary hyperoxaluria type 1 in The Netherlands: prevalence and outcome. Nephrol Dial Transplant 2003;18:273-9.
3. van Woerden CS, Groothoff JW, Wijburg FA, Annink C, Wanders RJ, Waterham HR. Clinical implications of mutation analysis in primary hyperoxaluria type 1. Kidney Int 2004;66:746-52.
4. Parks JH, Worcester EM, O'Connor RC, Coe FL. Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int 2003;63:255-65.
5. Soygur T, Akbay A, Kupeli S. Effect of potassium citrate therapy on stone recurrence and residual fragments after Shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. J Endourol 2002;16:149-52.